title: National guidelines and level of evidence: comments on some of the new recommendations in the American Society of Clinical Oncology and the College of American Pathologists human epidermal growth factor receptor 2 guidelines for breast cancer.
authors.affiliation: Nottingham University Hospitals NHS Trust; University of Nottingham, Nottingham City Hospital, Nottingham, United Kingdom emadrakha@yahoo.com Emad.rakha@nuh.nhs.uk.
authors.forename: Emad A
authors.initials: EA
authors.lastname: Rakha
authors.affiliation: Nottingham University Hospitals NHS Trust; University of Nottingham, Nottingham City Hospital, Nottingham, United Kingdom.
authors.forename: Marian
authors.initials: M
authors.lastname: Pigera
authors.affiliation: St James University Hospital, Leeds, United Kingdom.
authors.forename: Abeer
authors.initials: A
authors.lastname: Shaaban
authors.affiliation: New York Presbyterian Hospital, New York, NY.
authors.forename: Sandra J
authors.initials: SJ
authors.lastname: Shin
authors.affiliation: New York Presbyterian Hospital, New York, NY.
authors.forename: Timothy
authors.initials: T
authors.lastname: D'Alfonso
authors.affiliation: Nottingham University Hospitals NHS Trust; University of Nottingham, Nottingham City Hospital, Nottingham, United Kingdom.
authors.forename: Ian O
authors.initials: IO
authors.lastname: Ellis
authors.affiliation: Nottingham University Hospitals NHS Trust; University of Nottingham, Nottingham City Hospital, Nottingham, United Kingdom.
authors.forename: Andrew H S
authors.initials: AH
authors.lastname: Lee
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics*; D001943:Breast Neoplasms / Q000235:genetics*; D005260:Female; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases